Clinical Trial

OGTT at Home Using CGM vs at the Clinic

Study acronym: OGTT-CGM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-06
critical Primary endpoint(s) modified 2026-05-20
Trial Details
NCT Number NCT06862128
Lead Sponsor Linkoeping University
Collaborators: Region Jönköping County, Region Östergötland
Conditions Pre-diabetes, Diabetes
Enrollment 70 participants
Start Date 2025-06-11
Primary Completion 2026-05-21 (estimated)
Study Completion 2040-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-05